|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||
| Current Assets | |||||||||||||
| Cash and cash equivalents | |||||||||||||
| Other receivable - related party | |||||||||||||
| Restricted cash | |||||||||||||
| Accounts receivable, net | |||||||||||||
| Inventory, net | |||||||||||||
| Prepaid expenses and other current assets | |||||||||||||
| Total current assets | |||||||||||||
| Property and equipment, net | |||||||||||||
| Operating lease right-of-use asset | |||||||||||||
| Investment - related party | |||||||||||||
| Other assets | |||||||||||||
| Right-of-use assets, net | |||||||||||||
| Total Assets | |||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) | |||||||||||||
| Current Liabilities | |||||||||||||
| Accounts payable | |||||||||||||
| Accrued expenses and other current liabilities | |||||||||||||
| Operating lease liability | |||||||||||||
| Lease liabilities | |||||||||||||
| Total current liabilities | |||||||||||||
| Operating lease liability, non-current | |||||||||||||
| Lease liabilities, non-current | |||||||||||||
| Long-term debt, net | |||||||||||||
| Other liabilities | |||||||||||||
| Liabilities, Noncurrent | |||||||||||||
| Total Liabilities | |||||||||||||
| Redeemable convertible preferred stock | |||||||||||||
| Series A redeemable convertible preferred stock | |||||||||||||
| Total redeemable convertible preferred stock | |||||||||||||
| Stockholders’ Equity (Deficit) | |||||||||||||
| Preferred stock, $0.001 par value per share; 5,000,000 shares authorized; 0 outstanding | |||||||||||||
| Common stock, $0.001 par value per share; 1,000,000,000 shares authorized, 26,831,485 and 26,579,585 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively | |||||||||||||
| Additional paid-in capital | |||||||||||||
| Accumulated deficit | |||||||||||||
| Total Stockholders’ Equity (Deficit) | |||||||||||||
| Total Liabilities and Stockholders’ Equity (Deficit) | |||||||||||||
Loading...
